Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.

MLA

Zhang, Mingzhen, et al. “Edible Ginger-Derived Nanoparticles: A Novel Therapeutic Approach for the Prevention and Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer.” Biomaterials, vol. 101, Sept. 2016, pp. 321–40. EBSCOhost, https://doi.org/10.1016/j.biomaterials.2016.06.018.

APA

Zhang, M., Viennois, E., Prasad, M., Zhang, Y., Wang, L., Zhang, Z., Han, M. K., Xiao, B., Xu, C., Srinivasan, S., & Merlin, D. (2016). Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials, 101, 321–340. https://doi.org/10.1016/j.biomaterials.2016.06.018

Chicago

Zhang, Mingzhen, Emilie Viennois, Meena Prasad, Yunchen Zhang, Lixin Wang, Zhan Zhang, Moon Kwon Han, et al. 2016. “Edible Ginger-Derived Nanoparticles: A Novel Therapeutic Approach for the Prevention and Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer.” Biomaterials 101 (September): 321–40. doi:10.1016/j.biomaterials.2016.06.018.